SABINA ROWE: Open Payments
NPI 1669243234 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 29 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $203 |
| CVRx, Inc. | 7 | $149 |
| Recor Medical Inc | 1 | $124 |
| BridgeBio Pharma, Inc. | 5 | $91 |
| SCPHARMACEUTICALS INC. | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $34 |
| Baxter Healthcare | 1 | $26 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $22 |
Products named: Barostim Neo System, Paradise Ultrasound Renal Denervation System, LOKELMA, Attruby, FUROSCIX, Kerendia, QULIPTA, FARXIGA.
Industry payments across NY — which companies pay providers there.
